The FDA has expanded the indications for the appointment of an oral janus kinase 1 inhibitor

Pediatric pharmacology
Pediatričeskaâ farmakologiâ

ISSN 1727-5776 (Print)
ISSN 2500-3089 (Online)

eng | рус

Pediatric pharmacology

Advanced search

The FDA has expanded the indications for the appointment of an oral janus kinase 1 inhibitor. Pediatric pharmacology. 2023;20(1):92. (In Russ.)

ISSN 1727-5776 (Print)
ISSN 2500-3089 (Online)

Username
Password
	Remember me
Not a user? Register with this site Forgot your password?